Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Ondra Health vs Precision Telemed

Two GLP-1 desks, one scoreboard. We put Ondra Health and Precision Telemed head-to-head on the published Brief Score — the same six factors, scored the same way, no pay-to-win placement.

Higher Brief ScoreNo. 7 · Grade B+

Ondra Health

Visit Ondra Health Full brief →
vs
No. 16 · Grade B

Precision Telemed

Visit Precision Telemed Full brief →

The verdict

Ondra Health takes this head-to-head.

Ondra Health scores 87 to 85 on our six-factor Brief Score — A rare combination of a rock-bottom $93 semaglutide, brand-name access, LegitScript certification and all-50-state reach.

That doesn't make Precision Telemed a bad call — it's best for readers who want an accredited, no-frills nationwide option at a fair price. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
88
85
Supply Reliability
86
85
Transparency
88
87
Access Breadth
90
87
Clinical Oversight
88
86
Track Record
82
81
Ondra HealthBrief Score 87 · 85Precision Telemed

Price, coverage & the tracker

Ondra HealthPrecision Telemed
Brief Score87/100 (B+)85/100 (B)
Semaglutide$93/mo$149/mo
Tirzepatide$166/mo$199/mo
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableStableprice stable

Ondra Health: $93 sema / $166 tirz — the lowest accredited nationwide line we track; brand access + LegitScript.

Precision Telemed: $149 sema / $199 tirz nationwide; LegitScript-certified.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.